Chongsrimsirisakhol Onamon, Jangchud Kamolwan, Wilde Peter James, Pirak Tantawan
Department of Product Development, Faculty of Agro-Industry Kasetsart University Bangkok Thailand.
Quadram Institute Bioscience Norwich UK.
Food Sci Nutr. 2025 Apr 30;13(5):e70131. doi: 10.1002/fsn3.70131. eCollection 2025 May.
The ethanoic extract of hot-brew spent-coffee ground (HSCG) and cold-brew spent-coffee ground (CSCG) were prepared with ultrasound-assisted extraction and subjected to thermal processes and in vitro digestion prior to analyze the inhibition ability of advanced glycation end products (AGEs) formation, a potential risk factor for Alzheimer's disease. The obtained HSCG and CSCG extracts contained mainly chlorogenic acid derivatives, according to liquid chromatography-mass spectrometer chromatogram. The glycation process was performed by using bovine serum albumin (BSA)/ glucose system with 3 weeks incubation. In the presence of HSCG and CSCG extracts at 250 μg/mL, after thermal treatment (pasteurization and sterilization) and in vitro digestion, the glycation process through the fructosamine, AGEs, and amyloid cross β structure formation was monitored, and these extracts exhibited an anti-glycation property at early and advanced stages after pasteurization and in vitro digestion compared to no thermal treatment. However, at high temperature of sterilization, the suppress of anti-glycation property had resulted and were related with the amount of antioxidant and the ability of antioxidant scavenging as presented in a dose manner. The calculated % caffeine bio-accessibility of HSGC extracts was 65.8%, 64.8%, and 52.4% in non-thermal, pasteurized, and sterilized samples while the higher bio-accessibility was found in CSCG sample as of 67.4, 66.6, and 63.1, respectively. A high correlation of TPC values, thermal treatments and in vitro digestions with the AGEs was detected. Polyphenols and caffeine content in these extracts were found to be responsible for the AGEs and amyloid cross β structure inhibition which might potentially reduce the risk of Alzheimer's disease.
采用超声辅助萃取法制备了热冲泡咖啡渣(HSCG)和冷冲泡咖啡渣(CSCG)的乙酸提取物,并在分析晚期糖基化终产物(AGEs)形成(阿尔茨海默病的一个潜在风险因素)的抑制能力之前,对其进行了热处理和体外消化。根据液相色谱 - 质谱仪色谱图,所获得的HSCG和CSCG提取物主要含有绿原酸衍生物。糖基化过程通过使用牛血清白蛋白(BSA)/葡萄糖体系进行3周孵育。在250μg/mL的HSCG和CSCG提取物存在下,经过热处理(巴氏杀菌和灭菌)和体外消化后,监测了通过果糖胺、AGEs和淀粉样β交叉结构形成的糖基化过程,与未进行热处理相比,这些提取物在巴氏杀菌和体外消化后的早期和晚期均表现出抗糖基化特性。然而,在高温灭菌时,抗糖基化特性受到抑制,且与抗氧化剂的含量和抗氧化剂清除能力呈剂量相关。HSGC提取物在非热、巴氏杀菌和灭菌样品中的咖啡因生物可及性计算值分别为65.8%、64.8%和52.4%,而CSCG样品中的生物可及性更高,分别为67.4%、66.6%和63.1%。检测到总酚含量(TPC)值、热处理和体外消化与AGEs之间存在高度相关性。发现这些提取物中的多酚和咖啡因含量是抑制AGEs和淀粉样β交叉结构的原因,这可能会潜在降低阿尔茨海默病的风险。